CureMetrix plans to roll out its cmAngio AI software to SimonMed Imaging's network of U.S. physician radiology practices.
cmAngio has 501(k) clearance from the U.S. Food and Drug Administration (FDA), CureMetrix noted, adding that the software will be used to read mammograms and detect and localize breast arterial calcifications.
The software analyzes both full-field digital mammography and digital breast tomosynthesis screening mammograms to identify and mark these anomalies, according to CureMetrix.
"It allows radiologists to use existing screening mammograms to identify women who have breast arterial calcifications and as appropriate refer them for additional evaluation," CureMetrix said.
SimonMed Imaging operates in 10 states.
